Cumberland Pharmaceuticals (CPIX) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $15.2 million.
- Cumberland Pharmaceuticals' Cash & Current Investments fell 1298.62% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year decrease of 1298.62%. This contributed to the annual value of $18.0 million for FY2024, which is 195.09% down from last year.
- Latest data reveals that Cumberland Pharmaceuticals reported Cash & Current Investments of $15.2 million as of Q3 2025, which was down 1298.62% from $16.1 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Cash & Current Investments ranged from a high of $27.0 million in Q4 2021 and a low of $15.1 million during Q1 2025
- In the last 5 years, Cumberland Pharmaceuticals' Cash & Current Investments had a median value of $18.2 million in 2023 and averaged $19.3 million.
- In the last 5 years, Cumberland Pharmaceuticals' Cash & Current Investments tumbled by 3071.93% in 2022 and then surged by 1319.6% in 2024.
- Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Cash & Current Investments stood at $27.0 million in 2021, then dropped by 26.93% to $19.8 million in 2022, then fell by 7.27% to $18.3 million in 2023, then dropped by 1.95% to $18.0 million in 2024, then decreased by 15.41% to $15.2 million in 2025.
- Its Cash & Current Investments was $15.2 million in Q3 2025, compared to $16.1 million in Q2 2025 and $15.1 million in Q1 2025.